`Approved for use through 01131 [2014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995. no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`
`Application Data Sheet 37 CFR 1.76
`
`Attorney Docket Number 37901-715331
`
`.
`.
`Application Number
`
`
`
`Title of Invention
`
`MOLECULAR PROFILING OF TUMORS
`
`
`
`
`
`The application data sheet is part of the provisional or nonprovisional application for which it is being submitted. The following form contains the
`bibliographic data arranged in a format specified by the United States Patent and Trademark Office as outlined in 37 CFR 1.76.
`This document may be completed electronically and submitted to the Office in electronic format using the Electronic Filing System (EFS) or the
`document may be printed and included in a paper filed application.
`
`Secrecy Order 37 CFR 5.2
`Portions or all of the application associated with this Application Data Sheet may fall under a Secrecy Order pursuant to
`El 37 CFR 5.2 (Paper filers only. Applications that fall under Secrecy Order may not be filed electronically.)
`
`Inventor Information:
`
`
`Inventor
`
`1
`
`Legal Name
`
`Prefix Given Name
`
` Middle Name
`
`
`Family Name
`
`Residence Information (Select One)
`0 US Residency
`Non US Residency
`Active US Military Service
`City Icottsdale
`StatelProvince
`country of Residencd
`
`Mailing Address of Inventor:
`
`Address 1
`
`Address 2
`
`Postal Code
`
`
`
`Inventor
`
`
`Legal Name
`
` Given Name
`
`
`
`
`
`Residence Information (Select One) 6) US Residency
`
`Non US Residency
`
`Active US Military Service
`
`
`
`
`
`Mailing Address of Inventor:
`
`Address 1
`Address 2
`
`Postal Code
`
`Inventor
`
`I:
`
`Legal Name
`
`I262 Willow Circle Drive
`I
`
`I 6143
`
`_Ius
`
`
`Family Name
`Middle Name
`
`
`
`Residence Information (Select One) © US Residency
`Non US Residency
`Active US Military Service
`
`EFS Web 2.2.5
`
`
`
`PTOIAIAI14 (08-12)
`Approved for use through 0113112014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995. no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`
`Application Data Sheet 37 CFR 1.76
`
`Application Number
`
`Attorney Docket Number
`
`
`37901-715331
`
`
`
`
`
`
`MOLECULAR PROFILING OF TUMORS
`Title of Invention
`
`
`
`
`
`
`Mailing Address of Inventor:
`
`Address 1"00 E. Fillmore St. Apt 336
`Address 2
`I
`cm I— Staterprovince
`Postal Code
`I5oo4
`_IUS
`
`I.
`
`Inventor
`
`-
`
`
`
`
`
`Legal Name
`
`
`
`
`
`
`Prefix Given Name
`Middle Name
`Family Name
`
`Residence Information (Select One) © US Residency
`Non US Residency
`Active US Military Service
`
`
`
`
`
`
`
`Mailing Address of Inventor:
`
`I 534 West 300 North
`Address 1
`I
`Address 2
`cm I— staterrovince
`Postal Code
`I 6052-8244
`_IUS
`Inventor
`
`I'N
`
`Legal Name
`
`Residence Information (Select One) © US Residency
`
`Non US Residency
`
`Active US Military Service
`
`Mailing Address of Inventor:
`
`Address 1|.655 N. MacArthur Blvd.
`Address 2
`I
`cm I— Staterprovince
`Postal Code
`I 5039
`_IUS
`Inventor
`.
`
`Ix
`
`Legal Name
`
`
`
`
`Family Namew
`Middle Name
`IEI_ — _I
`
`
`
`Residence Information (Select One) © US Residency
`Non US Residency
`Active US Military Service
`_ StateIProvince
`Country of Residence_
`EFS Web 2.2.5
`
`
`
`
`
`
`
`PTOIAIAI14 (08-12)
`Approved for use through 0113112014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995. no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`
`Application Data Sheet 37 CFR 1.76
`
`Application Number
`
`Attorney Docket Number
`
`
`37901-715331
`
`
`
`
`
`
`MOLECULAR PROFILING OF TUMORS
`Title of Invention
`
`
`
`
`Mailing Address of Inventor:
`
`I 5485 Andorra Way
`Address 1
`I
`Address 2
`cm I— Staterprovince
`Postal Code
`[2129
`_Ius
`
`I A
`
`Inventor
`
`Legal Name
`
`
`
`
`Given Name
`Middle Name
`Family Name
`
`
`-— —I
`
`
`Residence Information (Select One) © US Residency
`Non US Residency
`Active US Military Service
`
`
`
`
`
` Address 1
`
`I . 15 W Edgemont Ave
`Address 2
`
`
`
`I
`I— Staterprovince
`
`
`US
`
` Postal Code ‘
`
`
`Mailing Address of Inventor:
`
`Inventor
`
`Legal Name
`
`
`
`Non US Residency
`Active US Military Service
`Residence Information (Select One) © US Residency
`Country of Residencé_
`City I aguna Hills
`StatelProvince
`
`
`
`
`
`
`
`
`Mailing Address of Inventor:
`
`Address 1
`
`Address 2
`
`
`
`Postal Code
`
`Inventor Information blocks may be
`Inventors Must Be Listed - Additional
`All
`generated within this form by selecting the Add button.
`
`Add
`
`Correspondence Information:
`
`Enter either Customer Number or complete the Correspondence Information section below.
`For further information see 37 CFR 1.33(a).
`
`|:| An Address is being provided for the correspondence Information of this application.
`Customer Number
`[6600
`EFS Web 2.2.5
`
`
`
`PTOIAIAI14 (08-12)
`Approved for use through 0113112014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`_
`_
`Application Data Sheet 37 CFR 1.76
`
`Attorney Docket Number
`_
`
`37901-715331
`
`_ Title of Invention
`
`MOLECULAR PROFILING OF TUMORS
`
`Email Address
`
`Application Information:
`
`
`
`_ddEmail Remove Email
`
`I—I
`
`Suggested Technology Center (if any)
`
`Total Number of Drawing Sheets (if any) I_ Suggested Figure for Publication (if any) I
`Publication Information:
`
`|:| Request Early Publication (Fee required at time of Request 37 CFR 1.219)
`
`El
`
`Request Not to Publish. I hereby request that the attached application not be published under
`35 U.S.C. 122(b) and certify that the invention disclosed in the attached application has not and will not be the
`subject of an application filed in another country, or under a multilateral international agreement, that requires
`publication at eighteen months after filing.
`
`
`
`Representative Information:
`
`Representative information should be provided for all practitioners having a power of attorney in the application. Providing
`this information in the Application Data Sheet does not constitute a power of attorney in the application (see 37 CFR 1.32).
`Either enter Customer Number or complete the Representative Name section below.
`If both sections are completed the customer
`Number will be used for the Representative Information during processing.
`
`Please Select One:
`Customer Number
`
`0 Customer Number
`
`US Patent Practitioner 0 Limited Recognition (37 CFR 11.9)
`
`Domestic BenefitINationaI Stage Information:
`
`
`I6600
`
`
`
`
`This section allows for the applicant to either claim benefit under 35 U.S.C. 119(e), 120, 121, or 365(c) or indicate
`National Stage entry from a PCT application. Providing this information in the application data sheet constitutes the
`specific reference required by 35 U.S.C. 119(e) or 120, and 37 CFR 1.78.
` Remove
`
`Prior Application Status
`
`
`
`
`Application Number
`Continuity Type
`Prior Application Number
`Filing Date (YYYY-MM-DD)
`—I_l
`555-5525
`
`
`
`
`
`Continuity Type
`Prior Application Number
`I_l14551345
`
`EFS Web 2.2.5
`
`Filing Date (YYYY-MM-DD)
`5555—55—25
`
`Application Number
`
`
`
`PTOIAIAI14 (08-12)
`Approved for use through 0113112014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995. no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`
`Application Data Sheet 37 CFR 1.76
`
`Application Number
`
`Attorney Docket Number
`
`
`37901-715331
`
`
`
`
`
`
`MOLECULAR PROFILING OF TUMORS
`Title of Invention
`
`
`
`
`Prior Application Status
`
`—:
`Prior Application
`Continuity Type
`Number
`I I14175781
`
`Application
`Number
`14551345
`
`I ontinuation of
`
`Filing Date
`(YYYY—MM—DD)
`If 014—02—07
`
`Patent Number
`I: 092392
`
`Issue Date
`(YYYY—MM-DD)
`I' 015—07—28
`
`.
`.
`Application
`ContInUIty Type
`Number
`l I12658770
`I ontinuation of
`14175781
`Prior Application Statusm
`Application Number
`Continuity Type
`
`Prior Application
`
`Prior Application StatusM
`Application Number
`Continuity Type
`
`Prior Application StatusM
`Application Number
`Continuity Type
`
`Prior Application Statusm
`Application Number
`Continuity Type
`
`Prior Application Statusm
`Application Number
`Continuity Type
`
`Filing Date
`(YYYY-M M-DD)
`If 010—02—12
`
`Patent Number
`I: 768629
`
`ISSUE Date
`(YYYY-MM-DD)
`I' 014-07-01
`
`Prior Application Number
`
`Filing Date (YYYY-MM-DD)
`
`Prior Application Number
`
`Filing Date (YYYY-MM-DD)
`
`Prior Application Number
`
`Filing Date (YYYY-MM-DD)
`
`Prior Application Number
`
`Filing Date (YYYY-MM-DD)
`
`Prior Application Number
`
`Filing Date (YYYY-MM-DD)
`
`
`Prior Application Number
`Filing Date (YYYY-MM-DD)
`
`
`
`
`Prior Application Statusm
`Application Number
`Continuity Type
`
`
`
`
`
`
`
`
`
`Prior Application Statusm
`Application Number
`Continuity Type
`Prior Application Number
`Filing Date (YYYY-MM-DD)
`
`Additional Domestic Benefit/National Stage Data may be generated within this form
`by selecting the Add button.
`
`Add
`
`
`
`Foreign Priority Information:
`
`This section allows for the applicant to claim benefit of foreign priority and to identify any prior foreign application for which priority is
`not claimed. Providing this information in the application data sheet constitutes the claim for priority as required by 35 U.S.C. 119(b)
`and 37 CFR 1.55(a)_
`
`
`
`
`
`
`EFS Web 2.2.5
`
`
`
`
`
`Priority Claimed
`
`
`
`
`Yes
`
`0 No
`
`
`
`PTOIAIAI14 (08-12)
`Approved for use through 0113112014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`_
`_
`Appllcatlon Data Sheet 37 CFR 1.76
`
`Attorney Docket Number
`_
`
`37901-715331
`
`_ Title of Invention
`
`MOLECULAR PROFILING OF TUMORS
`
`Additional Foreign Priority Data may be generated within this form by selecting the
`Add button.
`
`Authorization to Permit Access:
`
`X Authorization to Permit Access to the Instant Application by the Participating Offices
`
`If checked, the undersigned hereby grants the USPTO authority to provide the European Patent Office (EPO),
`the Japan Patent Office (JPO), the Korean Intellectual Property Office (KIPO), the World Intellectual Property Office (WIPO),
`and any other intellectual property offices in which a foreign application claiming priority to the instant patent application
`is filed access to the instant patent application. See 37 CFR 1.14(c) and (h). This box should not be checked if the applicant
`does not wish the EPO, JPO, KIPO, WIPO, or other intellectual property office in which a foreign application claiming priority
`to the instant patent application is filed to have access to the instant patent application.
`
`In accordance with 37 CFR 1.14(h)(3), access will be provided to a copy of the instant patent application with respect
`to: 1) the instant patent application-as—filed; 2) any foreign application to which the instant patent application
`claims priority under 35 U.S.C. 119(a)—(d) if a copy of the foreign application that satisfies the certified copy requirement of
`37 CFR 1.55 has been filed in the instant patent application; and 3) any US. application—as—filed from which benefit is
`sought in the instant patent application.
`
`In accordance with 37 CFR 1.14(c), access may be provided to information concerning the date of filing this Authorization.
`
`
`
`Applicant Information:
`
`Providing assignment information in this section does not substitute for compliance with any requirement of part 3 of Title 37 of CFR
`to have an assignment recorded by the Office.
`
`Applicant
`
`1
`
`If the applicant is the inventor (or the remaining joint inventor or inventors under 37 CFR 1.45), this section should not be completed.
`The information to be provided in this section is the name and address of the legal representative who is the applicant under 37 CFR
`1.43; or the name and address of the assignee, person to whom the inventor is under an obligation to assign the invention, or person
`who otherwise shows sufficient proprietary interest in the matter who is the applicant under 37 CFR 1.46. If the applicant is an
`applicant under 37 CFR 1.46 (assignee, person to whom the inventor is obligated to assign, or person who otherwise shows sufficient
`proprietary interest) together with one or more joint inventors, then the joint inventor or inventors who are also the applicant should be
`identified in this section.
`
`
`Joint Inventor
`
`o Assignee
`
`
`
`
`Q
`
`
`
`Legal Representative under 35 U.S.C. 117
`
`Person to whom the inventor is obligated to assign.
`Person who shows sufficient proprietary interest
`
`
`If applicant is the legal representative, indicate the authority to file the patent application, the inventor is:
`
`Name of the Deceased or Legally lncapacitated Inventor::|
`
`If the Applicant is an Organization check here.
`EFS Web 2.2.5
`
`
`
`PTOIAIAI14 (08-12)
`Approved for use through 0113112014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995. no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`_
`_
`
`Appllcatlon Data Sheet 37 CFR 1.76
`
`Attorney Docket Number
`_
`_
`
`37901-715331
`
`
`
`
`
`
`
`Title of Invention
`
`MOLECULAR PROFILING OF TUMORS
`
`Mailing Address Information:
`Address 1'655 North MacArthur Blvd.
`Address 2
`I
`my
`I——I x
`com» I_—I
`I——I
`I
`
`Email Address
`
`Additional Applicant Data may be generated within this form by selecting the Add button.
`
`Non-Applicant Assignee Information:
`
`
`
`
`
`
`
`Providing assignment information in this section does not subsitute for compliance with any requirement of part 3 of Title 37 of CFR to
`have an assignment recorded by the Office.
`
`Assignee
`
`1
`
`Complete this section only if non-applicant assignee information is desired to be included on the patent application publication in
`accordance with 37 CFR 1.215(b). Do not include in this section an applicant under 37 CFR 1.46 (assignee, person to whom the
`inventor is obligated to assign, or person who otherwise shows sufficient proprietary interest), as the patent application publication will
`include the name of the applicant(s).
`Remove
`
`
`
`If the AssigneeIs an Organization check here.
`
`Mailing Address Information:
`
`Address 2
`city
`
`I
`I——I—
`I——I—
`
`
`
`
`Additional Assignee Data may be generated within this form by selecting the Add button.
`
`Add
`
`EFS Web 2.2.5
`
`
`
`PTOIAIAI14 (08-12)
`Approved for use through 0113112014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995. no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`_
`_
`Appllcatlon Data Sheet 37 CFR 1.76
`
`Attorney Docket Number
`_
`
`37901-715331
`
`MOLECULAR PROFILING OF TUMORS
`
`_ Title of Invention
`Additional Signature may be generated within this form by selecting the Add button.
`
`Signature:
`
`NOTE: This form must be signed in accordance with 37 CFR 1.33. See 37 CFR 1.4 for signature requirements and
`certifications
`
`W‘ Ramin Akhavan.’
`
`‘ Date (YYYY-MM-DD) I'O16—06—24
`
`This collection of information is required by 37 CFR 1.76. The information is required to obtain or retain a benefit by the public which
`is to file (and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This
`collection is estimated to take 23 minutes to complete, including gathering, preparing, and submitting the completed application data
`sheet form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time you require to
`complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, US. Patent and
`Trademark Office, US. Department of Commerce, PO. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR
`COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents. P.O. Box 1450, Alexandria, VA 22313-1450.
`
`EFS Web 2.2.5
`
`
`
`Privacy Act Statement
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1.
`
`The information on this form will be treated confidentially to the extent allowed under the Freedom of Information Act (5 U.S.C. 552)
`and the Privacy Act (5 U.S.C. 552a). Records from this system of records may be disclosed to the Department of Justice to determine
`whether the Freedom of Information Act requires disclosure of these records.
`
`A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence to a court, magistrate, or
`administrative tribunal, including disclosures to opposing counsel in the course of settlement negotiations.
`
`A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting a request involving an
`individual, to whom the record pertains, when the individual has requested assistance from the Member with respect to the subject matter of
`the record.
`
`A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency having need for the information in
`order to perform a contract. Recipients of information shall be required to comply with the requirements of the Privacy Act of 1974, as
`amended, pursuant to 5 U.S.C. 552a(m).
`
`A record related to an International Application filed under the Patent Cooperation Treaty in this system of records may be disclosed,
`as a routine use, to the International Bureau of the World Intellectual Property Organization, pursuant to the Patent Cooperation Treaty.
`
`A record in this system of records may be disclosed, as a routine use, to another federal agency for purposes of National Security
`review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C. 218(c)).
`
`A record from this system of records may be disclosed, as a routine use, to the Administrator, General Services, or hisfher designee,
`during an inspection of records conducted by GSA as part of that agency's responsibility to recommend improvements in records
`management practices and programs, under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall be made in accordance with the
`GSA regulations governing inspection of records for this purpose, and any other relevant (i.e., GSA or Commerce) directive. Such
`disclosure shall not be used to make determinations about individuals.
`
`a patent application or patent. Accordingly, pursuant to the requirements of the Act, please be advised that: (1) the general authority for the collection
`of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary; and (3) the principal purpose for which the information is
`used by the U.S. Patent and Trademark Office is to process and/or examine your submission related to a patent application or patent.
`If you do not
`furnish the requested information, the US. Patent and Trademark Office may not be able to process andlor examine your submission, which may
`result in termination of proceedings or abandonment of the application or expiration of the patent.
`
` The Privacy Act of 1974 (PL. 93—579) requires that you be given certain information in connection with your submission of the attached form related to
`
`
`
`A record from this system of records may be disclosed, as a routine use, to the public after either publication of the application pursuant
`to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37
`CFR 1.14, as a routine use, to the public if the record was filed in an application which became abandoned or in which the proceedings were
`terminated and which application is referenced by either a published application, an application open to public inspections or an issued
`patent.
`
`A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law enforcement agency, if the
`USPTO becomes aware of a violation or potential violation of law or regulation.
`
`
`EFS Web 2.2.5
`
`